Aridis Pharmaceuticals, Inc. ( ARDS) - Key Metrics
ARDS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2023Q3 | $0.01 | $0 | -$0.03 | -$0.03 |
| 2023Q2 | $0.54 | $0.34 | -$0.12 | -$0.12 |
| 2023Q1 | $0 | -$0.22 | -$0.13 | -$0.13 |
| 2022Q4 | $0 | -$0.35 | -$0.47 | -$0.47 |
| 2022Q3 | $0 | -$0.51 | -$0.24 | -$0.24 |
ARDS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2023Q3 | 0% | -11.60 |
| 2023Q2 | 0% | 0.16 |
| 2023Q1 | 0% | -0.36 |
| 2022Q4 | 0% | -0.84 |
| 2022Q3 | 0% | -0.46 |
ARDS
Price: $0
52 week price:
Earnings Per Share: -0.02 USD
P/E Ratio: -0.01
Exchange: OEM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 543871
Market Capitalization: 4457